Miami Cancer Institute publication analyzes r : comparemela.

<p>Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in <em>Trends in Cancer</em> that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs).</p>

Related Keywords

Boston , Massachusetts , United States , Florida , Florida Keys , Miami , America , Manmeets Ahluwalia , Atulyaa Khosla , Vivek Subbiah , Bayer Incyte , Eli Lilly , Ahmad Ozair , Roche Genentech , Caris Lifesciences , Mohamed Gouda , Fernandez Family Foundation , Boston Pharmaceuticals , Varian Medical Systems , Idera Pharmaceuticals Incyte , National Comprehensive Cancer Network , Miami Cancer Institute , Pfizer , Baptist Health South Florida , Glaxosmithkline , Novartis , Method Of Research , Md Anderson Cancer Center , Medinnovate Advisors , Cancer Research At Miami Institute , Amgen , Astrazeneca , Fujifilm , Baptist Health Cancer Care , Fernandez Family Foundation Endowed Chair , Cancer Research , Cancer Institute , South Florida , Latin America , Memorial Sloan Kettering Cancer , Voyager Therapeutics , Pyramid Biosciences , Cairn Therapeutics , Anheart Therapeutics , Scientific Advisory Board , Blueprint Medicines , Boston Biomedical , Dragonfly Therapeutics , Idera Pharmaceuticals , Loxo Oncology , Relay Therapeutics , Turning Point Therapeutics , Cancer Center , Helsinn Healthcare ,